Piperidine-4 sulphonamide compounds
US6323217A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2001 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Jan 30, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound of formula (I): ##STR1## wherein: PA1 R.sub.1 represents hydrogen or alkyl, PA1 R.sub.2a and R.sub.2b represent a group selected from hydrogen, halogen, alkyl, hydroxy, alkoxy, trihaloalkyl, cyano, nitro, amino, alkylamino and dialkylamino, PA1 R.sub.3 represents hydrogen or hydroxy, PA1 X represents oxygen or methylene, PA1 V represents an alkylene chain that is optionally unsaturated and optionally substituted, PA1 U represents a bond or an alkylene chain, PA1 W represents a group selected from aryl and heteroaryl, each of those groups being optionally substituted by one or more identical or different groups, its isomers, its hydrates, its solvates and addition salts thereof with a pharmaceutically acceptable acid. Medicinal products containing the same which are useful in the treatment of diseases or pathological conditions in which endothelial dysfunction is known.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.